Showing results (51-60 of 121) with videos related to
Sort By:
Pageof 13
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 5, 2017
Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM studyM B Zanchetta, J Boailchuk, F Massari, et al.Nephron|January 1, 1996
Bone mineral density in patients with hypercalciuric nephrolithiasisJ R Zanchetta, G Rodriguez, A L Negri, et al.Annals of the New York Academy of Sciences|May 22, 2002
Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus under the age of 20 yearsC Betterle, A Fusari, F Presotto, et al.Current Osteoporosis Reports|December 7, 2010
Denosumab: What's new?Cesar E Bogado, Maria Belen Zanchetta, Juan A Boailchuk, et al.Transplantation Proceedings|April 26, 2005
Evaluation of cortical bone by peripheral quantitative computed tomography in renal transplant recipientsA L Negri, C Lombas, C Cuevas, et al.Medicina|January 1, 1997
[Extended use, up to 6 years, of an oral amino-bisphosphonate in patients with established osteoporosis]J R Zanchetta, R F Spivacow, C Bogado, et al.International Urology and Nephrology|August 5, 2009
Clinical and metabolic risk factor evaluation in young adults with kidney stonesFrancisco R Spivacow, Armando L Negri, Elisa E del Valle, et al.Diabetes Care|August 11, 2000
Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infectionC Betterle, P Fabris, R Zanchetta, et al.Medicina|January 1, 1997
[Experimental effects of olpadronate and pamidronate on bone mass]N Mondelo, M D Parma, V A Peluffo, et al.Drugs of Today (Barcelona, Spain : 1998)|August 19, 2011
Denosumab: an updateCesar E Bogado, J A Boailchuk, M B Zanchetta, et al.Pageof 13